| Literature DB >> 32708379 |
Sophie Bérard1,2, Sophia Morel1,2, Emma Teasdale1, Nitin Shivappa3,4, James R Hebert3,4, Caroline Laverdière5, Daniel Sinnett5, Emile Levy1,2, Valérie Marcil1,2.
Abstract
There is little information about how diet influences the health of childhood acute lymphoblastic leukemia (cALL) survivors. This study explores the associations between diet quality indices, cardiometabolic health indicators and inflammatory biomarkers among cALL survivors. Participants were part of the PETALE study (n = 241, median age: 21.7 years). Adherence to 6 dietary scores and caloric intake from ultra-processed foods were calculated. Multivariate logistirac regressions, Student t-tests and Mann-Whitney tests were performed. We found that 88% of adults and 46% of children adhered poorly to the Mediterranean diet, 36.9% had poor adherence to the World Health Organisation (WHO) recommendations and 76.3% had a diet to be improved according to the HEI-2015 score. On average, ultra-processed foods accounted for 51% of total energy intake. Low HDL-C was associated with a more inflammatory diet (E-DIITM score) and higher intake of ultra-processed foods. A greater E-DII score was associated with elevated insulin resistance (HOMA-IR), and consumption of ultra-processed foods was correlated with high triglycerides. Circulating levels of TNF-α, adiponectin and IL-6 were influenced by diet quality indices, while CRP and leptin were not. In conclusion, survivors of cALL have poor adherence to dietary recommendations, adversely affecting their cardiometabolic health.Entities:
Keywords: acute lymphoblastic leukemia; cardiometabolic complications; dietary scores; nutrition; oncology; pediatrics; survivors
Mesh:
Substances:
Year: 2020 PMID: 32708379 PMCID: PMC7400871 DOI: 10.3390/nu12072137
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic and clinical characteristics of participants.
| Total | Adults | Children | |
|---|---|---|---|
| Median (range or interquartile range 1) | |||
| Age at visit, years (range) | 21.3 (8.5–40.9) | 24.6 (18.0–40.9) | 16.2 (8.5–17.9) |
| Age at cancer diagnosis, years (range) | 4.7 (0.9–18.0) | 6.5 (0.9–18.0) | 3.5 (1.3–10.9) |
| Time since end of treatment, years (range) | 12.9 (3.3–26.1) | 16.11 (3.9–26.1) | 9.6 (3.3–13.4) |
| Gender (males, %) | 49.4 | 49.4 | 49.4 |
| CRT exposure ( | 142 (58.9%) | 108 (69.2%) | 34 (40.0%) |
| BMI (kg/m2) | 23.5 (20.9–26.1) | 24.3 (21.7–27.4) | 21.8 (19.2–24.1) |
| WHtR | 0.50 (0.46–0.55) | 0.51 (0.48–0.58) | 0.49 (0.45–0.52) |
| WC (cm) | 85.7 (76.0–93.0) | 89.0 (79.5–97.0) | 79.9 (72.0–84.0) |
| Glucose (mmol/L) | 5.0 (4.8–5.3) | 5.0 (4.8–5.4) | 5.0 (4.8–5.3) |
| Insulin (pmol/L) | 53.3 (37.6–75.8) | 50.1 (35.2–68.6) | 58.1 (42.9–81.1) |
| HOMA-IR | 1.7 (1.2–2.5) | 1.7 (1.1–2.3) | 1.9 (1.3–2.7) |
| TC (mmol/L) | 4.37 (3.87–5.01) | 4.59 (4.10–5.15) | 4.18 (3.61–4.63) |
| TG (mmol/L) | 0.91 (0.66–1.25) | 0.97 (0.72–1.38) | 0.82 (0.62–1.07) |
| LDL-C (mmol/L) | 2.57 (2.13–3.16) | 2.73 (2.22–3.32) | 2.36 (2.04–2.82) |
| HDL-C (mmol/L) | 1.30 (1.12–1.49) | 1.31 (1.13–1.52) | 1.29 (1.09–1.45) |
| SBP (mmHg) | 115 (108–124) | 117 (110–125) | 112 (104–119) |
| DBP (mmHg) | 65 (59–70) | 67 (63–72) | 62 (57–65) |
| Apo A1 (mg/mL) | 2.32 (1.94–2.65) | 2.46 (1.98–2.72) | 2.18 (1.90–2.52) |
| Apo B100 (g/L) | 0.82 (0.71–0.94) | 0.85 (0.72–0.97) | 0.79 (0.68–0.92) |
1 Interquartile range: 25th and 75th percentiles, unless otherwise specified. CRT, cranial radiation therapy; BMI, body mass index; WHtR, waist-to-height ratio; WC, waist circumference; HOMA-IR, homeostasis model assessment-insulin resistance; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Descriptive statistics of the dietary scores.
| Score (Range) |
| Mean | Median | SD | Min | Max |
|---|---|---|---|---|---|---|
| MEDAS (0–14) | 156 | 4.26 | 4.00 | 1.87 | 1.00 | 10.00 |
| KIDMED (−4–12) | 85 | 3.45 | 4.00 | 2.36 | −2.00 | 9.00 |
| HDI-2018 (0–9) | 241 | 4.06 | 4.00 | 1.56 | 0.00 | 9.00 |
| HEI-2015 (0–100) | 241 | 59.78 | 60.00 | 10.58 | 35.00 | 85.00 |
| E-DII (−8.87–7.98) | 241 | −0.92 | −1.06 | 1.61 | −4.80 | +3.23 |
| FRAP (≥0 mmol/day) | 241 | 11.89 | 9.78 | 7.64 | 1.96 | 48.79 |
| % UPF (0–100%) 1 | 191 | 51.33 | 50.69 | 16.11 | 6.93 | 93.36 |
1 Percentage of caloric intake from ultra-processed foods (Group 4) based on the NOVA classification. MEDAS, Mediterranean Diet Adherence Screener; KIDMED, Mediterranean Diet Quality Index for children and adolescents; HDI-2018, Healthy Diet Indicator; HEI-2015, Healthy Eating Index; E-DII, Energy-adjusted dietary Inflammatory Index; FRAP, Ferric reducing ability of plasma; UPF, Ultra-processed foods; SD, standard deviation; Min, minimum; Max, maximum.
Figure 1Distribution of the dietary scores among participants. (a) MEDAS (Mediterranean Diet Adherence Screener) score; (b) KIDMED (Mediterranean Diet Quality Index for children and adolescents) score; (c) HDI (Healthy Diet Indicator)-2018 score; (d) HEI (Healthy Eating Index)-2015 score; (e) E-DII (Energy-adjusted dietary Inflammatory Index) score; (f) FRAP (Ferric reducing ability of plasma) score; (g) contribution of ultra-processed foods according to the NOVA classification.
Associations between adherence to E-DII score and anthropometric and metabolic parameters.
| E-DII Score | |||||||
|---|---|---|---|---|---|---|---|
| Parameters | Tertile 1 | Tertile 2 | Tertile 3 | ||||
| −2.67 | −1.05 | 0.97 | |||||
| OR (95% CI) | OR (95% CI) 2 |
| OR (95% CI) 2 |
| OR (95% CI) 2 |
| |
| High | - | 1.297 | 0.59 | 1.260 | 0.65 | 1.280 | 0.57 |
| High | - | 1.089 | 0.81 | 1.574 | 0.22 | 1.283 | 0.43 |
| High | - | 3.029 |
| 1.135 | 0.83 | 1.928 | 0.21 |
| High | - | 2.667 | 0.03 | 1.349 | 0.56 | 2.047 | 0.09 |
| Low | - | 2.318 | 0.04 | 2.414 | 0.04 | 2.359 | 0.02 |
| High | - | 1.200 | 0.68 | 1.183 | 0.72 | 1.192 | 0.66 |
| High | - | 0.937 | 0.90 | 1.658 | 0.31 | 1.240 | 0.63 |
1 Mean score (range); 2 Model adjusted for gender and survival time. Cut-off values are described in Supplementary Table S1. OR, odds ratio; CI, confidence interval; BMI, body mass index; WC, waist circumference; BP, blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides.
Associations between ultra-processed foods and anthropometric and metabolic parameters.
| % Ultra-Processed Foods According to the NOVA Classification | |||||||
|---|---|---|---|---|---|---|---|
| Parameters | Tertile 1 | Tertile 2 | Tertile 3 | ||||
| 34.2% | 50.0% | 69.3% | |||||
| OR (95% CI) | OR (95% CI) 2 |
| OR (95% CI) 2 |
| OR (95% CI) 2 |
| |
| High | - | 0.360 | 0.11 | 0.929 | 0.89 | 0.619 | 0.30 |
| High | - | 0.622 | 0.24 | 0.968 | 0.94 | 0.772 | 0.45 |
| High | - | 0.781 | 0.68 | 1.078 | 0.89 | 0.934 | 0.89 |
| High | - | 0.341 | 0.06 | 0.763 | 0.58 | 0.533 | 0.14 |
| Low | - | 1.410 | 0.48 | 3.885 |
| 2.323 |
|
| High | - | 0.407 | 0.09 | 0.728 | 0.50 | 0.556 | 0.16 |
| High | - | 2.998 | 0.12 | 5.434 |
| 4.021 |
|
1 Mean score (range); 2 Model adjusted for gender, survival time and energy intake. Cut-off values are described in Supplementary Table S1. OR, odds ratio; CI, confidence interval; BMI, body mass index; WC, waist circumference; BP, blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides.
Association between adherence to nutritional scores and having ≥2 cardiometabolic complications.
| Presence of 2 or More Cardiometabolic Complications | |||||||
|---|---|---|---|---|---|---|---|
| Scores | OR (95% CI) | OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
|
| MEDAS 2 | - | 0.800 | 0.63 | 1.380 | 0.30 | 1.279 | 0.54 |
| KIDMED 2 | - | 0.424 | 0.20 | 0.735 | 0.61 | 0.728 | 0.56 |
| HDI-2018 2 | - | 1.079 | 0.84 | 1.191 | 0.63 | 0.728 | 0.56 |
| HEI-2015 3 | - | 1.053 | 0.88 | 0.750 | 0.44 | 0.911 | 0.77 |
| E-DII 3 | - | 2.506 |
| 1.613 | 0.23 | 2.076 |
|
| FRAP 2 | - | 1.509 | 0.27 | 1.245 | 0.58 | 1.391 | 0.33 |
| % UPF 2,4 | - | 0.647 | 0.30 | 1.128 | 0.77 | 0.856 | 0.66 |
Presence of at least two of these four factors: obesity, pre-hypertension/hypertension, insulin resistance and dyslipidemia; 2 Model adjusted for gender, survival time and energy intake; 3 Model adjusted for gender and survival time; 4 %UPF, percentage of contribution of ultra-processed foods to total dietary energy intake using NOVA classification. OR, odds ratio; CI, confidence interval.
Figure 2Inflammatory biomarker levels (y axis) according to nutritional scores (x axis). (a) TNF-α (pg/mL) in non-obese; (b) TNF-α in obese; (c) adiponectin (ng/mL) in non-obese; (d) adiponectin level in obese; * p < 0.05 tertile 3 vs. 1; ϯ p < 0.05 tertile 2 vs. 1. MEDAS, Mediterranean Diet Adherence Screener; KIDMED, Mediterranean Diet Quality Index for children and adolescents; HDI-2018, Healthy Diet Indicator; HEI-2015, Healthy Eating Index; E-DII, Energy-adjusted dietary Inflammatory Index; FRAP, Ferric reducing ability of plasma; Ultra-processed foods.